<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

First-in-Class PIKfyve Kinase Inhibitor for B-NHL Identified

Non-Hodgkin lymphoma (NHL) covers a group of lymphoproliferative malignancies with subtypes ranging from slow growing to aggressive, and which have different responses to available standard of care therapies.